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Objective: To determine the most useful findings of gadoxetic acid-enhanced 3.0 Tesla (T) MRI for differentiating focal 
eosinophilic infiltration (FEI) from hepatic metastasis with verification of their usefulness.
Materials and Methods: Pathologically or clinically proven 39 FEIs from 25 patients and 79 hepatic metastases from 51 
patients were included in the study. Gadoxetic acid-enhanced 3.0T MRI was performed in all cancer patients. Size 
differences measured between T2-weighted and hepatobiliary-phase images for lesions > 1 cm and morphologic findings 
(margin, shape, signal intensity on T1- and T2-weighted images, enhancement pattern on dynamic images, and target 
appearance on hepatobiliary-phase images) were compared between two groups via Student’s t test as well as univariate 
and multivariate analyses. Diagnostic predictive values of two observers for differentiating two groups were assessed before 
(session 1) and after (session 2) recognition of results.
Results: Mean size difference (2.1 mm) in FEIs between the two images was significantly greater than for metastases (0.7 
mm) (p < 0.05). An ill-defined margin and isointensity on T1-weighted images were independently significant morphologic 
findings (p < 0.05) for differentiating the two groups. All observers achieved a higher diagnostic accuracy in session 2 (97% 
and 98%) than session 1 (92% and 89%) with statistical significance in observer 2 (p < 0.05). All observers had 
significantly higher sensitivities (95%) and negative predictive values (NPVs) (98%) in session 2 than in session 1 
(sensitivity, 74% in two observers; NPV, 89% and 88%) (p < 0.05).
Conclusion: With the size change, an ill-defined margin and isointensity on T1-weighted images are the most useful 
findings for differentiating FEI from hepatic metastasis on gadoxetic acid-enhanced 3.0T MRI.
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INTRODUCTION
Focal eosinophilic infiltration (FEI) of the liver is 
associated with a variety of eosinophilia-related conditions 
including parasitic infestation, allergic reactions, 
hypereosinophilic syndrome, and internal malignancies 
including lymphoma, leukemia, and cancer of the lung, 
stomach, pancreas, or ovary (1-5). Several investigators (6-
12) have reported the differential radiologic findings of FEI 
from metastasis in the liver based on sonography, CT, and 
MRI with gadopentetate dimeglumine (Magnevist; Schering 
AG, Berlin, Germany) or gadobenate dimeglumine-enhanced 
MRI (Gd-BOPTA; MultiHance, Bracco SpA, Milan, Italy) using 
1.5 Tesla (T). Although specific radiologic findings of FEI 
in the liver have been previously reported (6-12), it is still 
difficult to differentiate these foci from hepatic metastasis 
in patients with extrahepatic malignancies.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 440
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Currently, liver MRI using 3.0T with improved image 
quality due to greater signal-to-noise ratio has been 
increasingly used for the detection and characterization 
of focal liver lesions. The recently developed hepatobiliary 
agent, gadoxetic acid (Gadolinium-ethoxybezyl [Gd-
EOB]-DTPA, Primovist, Bayer Schering Pharma, Berlin), 
is taken up preferentially by hepatocytes and evidences 
prolonged persistence in the liver, owing to the fact 
that approximately 50% of the injected dose is taken 
up by functioning hepatocytes and excreted in the bile, 
as compared with an uptake of 3-5% for gadobenate 
dimeglumine and hepatocyte-specific phase imaging after 
the injection of gadoxetic acid, which can be obtained 
earlier than gadobenate dimeglumine (13-15). Some 
investigators (16, 17) have previously reported that 
gadoxetic acid-enhanced MRI allows for the accurate 
detection and characterization of focal liver lesions.
To the best of our knowledge, there have been no 
reports outlining the most decisive radiologic findings to 
differentiate FEI from hepatic metastasis using gadoxetic 
acid-enhanced 3.0T MRI. Therefore, the purpose of this 
study was to evaluate and verify the most useful findings of 
gadoxetic acid-enhanced 3.0T MRI in the differentiation of 
FEI from hepatic metastasis.
MATERIALS AND METHODS
Patients
The Institutional Review Board approved this 
retrospective study, and informed consent was not 
required. Using a computerized search of our hospital’s 
radiological and pathological information systems from 
May 2008 to March 2009, a total of 594 cancer patients 
with metastasis and a total of 38 patients with FEIs in the 
liver were included in the study. Among them, 51 cancer 
patients with 79 metastases and 25 cancer patients with 
39 FEIs underwent gadoxetic acid-enhanced 3.0T MRI. The 
patients with metastases were selected solely on the basis 
of histopathological confirmation. Pathological diagnoses 
of FEI and metastasis were rendered after a percutaneous 
biopsy (n = 4, n = 10, respectively), or partial hepatic 
resection (n = 2, n = 69, respectively). The FEIs (n = 33) 
that were not pathologically confirmed were clinically 
diagnosed by consideration of initial peripheral eosinophilia 
(> 10%), spontaneous disappearance on follow-up imaging, 
and normalized peripheral blood eosinophilic count (7). The 
number of FEIs in the liver for a given patient ranged from 
one in 17 patients, two in six patients, three in one patient, 
and seven in one patient. The number of metastases for a 
given patients ranged from one in 35 patients, two in nine 
patients, three in four patients, four in one patient, and 
five in two patients.
In 25 patients with FEI in the liver, the primary 
malignancies included adenocarcinoma in the stomach (n 
= 10), colorectum (n = 12), cervix (n = 1), breast (n = 1), 
and common bile duct (n = 1). The patients included 20 
men and five women, ranging in age from 35 to 64 years 
(mean, 56 years). In 51 patients with hepatic metastasis 
(M:F = 31:20; age range, 31-83 years; mean age, 59 years), 
the primary malignancies included adenocarcinoma in the 
colorectum (n = 42), stomach (n = 3), pancreas (n = 2) 
and gallbladder (n = 1); neuroendocrine carcinoma in the 
pancreas (n = 2); and malignant gastrointestinal stromal 
tumor in the small bowel (n = 1). 
MRI Examinations
All MR images were acquired with a 3.0T whole-body 
MRI system (Intera Achieva 3.0T, Philips Healthcare) with 
a 16-channel phased-array coil used as the receiver coil. 
The liver was imaged in the axial plane in all patients, 
both prior to and after administration of gadoxetic acid at 
a dose of 0.1 mL/kg (0.25 mmol/mL). The contrast agent 
was automatically intravenously administered at a rate of 
2 mL/s with a power injector, followed by a 20-mL saline 
flush. The MRI protocol included a respiration-triggered T1-
weighted turbo field-echo in-phase sequence (repetition 
time [TR]/echo time [TE], 10/2.3; flip angle, 15°; matrix 
size, 288 × 230; bandwidth, 434.3 Hz/pixel) and an out-
of-phase sequence (10/3.45; flip angle, 15°; matrix size, 
288 × 230; bandwidth, 434.3 Hz/pixel), a respiration-
triggered single-shot T2-weighted sequence with a 
reduction factor of 2 or 4 (1342/80; flip angle, 90°; matrix 
size, 320 × 256; bandwidth, 506.4 Hz/pixel), a breath-
hold multishot T2-weighted sequence with a reduction 
factor of 2 or 4 (2161/70; flip angle, 90°; matrix size, 400 
× 280; bandwidth, 235.2 Hz/pixel), a respiration-triggered 
single-shot heavily T2- weighted sequence with a reduction 
factor of 2 or 4 (1573/160; flip angle, 90°; matrix size, 
320 × 256; bandwidth, 317.9 Hz/pixel) with a 5- to 7-mm 
section thickness and a 1- to 2-mm intersection gap, and 
a field of view of 32-38 cm. For gadoxetic acid-enhanced 
MRI, unenhanced, arterial-phase (20-35 seconds), portal-
phase (60 seconds), late-phase (3 minutes), and 20-minute 
delayed hepatobiliary-phase images were obtained using Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 441
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a T1-weighted 3D turbo field-echo sequence (T1 high-
resolution isotropic volume examination, THRIVE, Philips 
Healthcare) (3.4/1.8; flip angle, 10°; matrix size, 336 
× 206; bandwidth, 995.7 Hz/pixel) with a 2-mm section 
thickness, no intersection gap, and a field of view of 32-38 
cm.
Image Analysis
Quantitatively, one author measured the maximum 
dimension of the lesions 1 cm in diameter or larger in 
order to reduce any measurement inaccuracies resulting 
from partial volume effects on both T2-weighted and 
hepatobiliary-phase images. The three consecutive time 
measurements of a lesion were averaged, and this average 
was chosen as the maximum dimension of the lesion. 
Qualitatively, morphologic MRI findings of 39 FEIs and 
79 hepatic metastases were reviewed by consensus of 
two experienced radiologists. The following findings were 
evaluated: margin, shape, signal intensity on T1- and 
T2-weighted images, and the enhancement pattern on 
gadoxetic acid-enhanced arterial, portal, and 3-minute 
late phases. Additionally, the presence or absence of target 
appearance on hepatobiliary-phase images was assessed.
The margin of the lesion was divided as either ill- and 
well-defined. A well-defined margin was considered as a 
clear demarcation of the entire lesion on hepatobiliary-
phase images. The shape of the lesion was divided into 
non-spherical and spherical categories. A lesion was defined 
as spherical when it showed a round or oval shape based 
on the combined T2-weighted and hepatobiliary-phase 
images; a lesion was defined as non-spherical when it 
showed any shape other than a round or oval shape based 
on the combined T2-weighted and hepatobiliary-phase 
images. The contrast enhancement pattern of the lesion was 
evaluated at the arterial, portal, and 3-minute late phases 
into two types and divided according to the presence or 
absence of rim enhancement (contrast enhancement at the 
periphery of the lesion). As seen on the arterial, portal, 
and 3-minute late phases, contrast enhancement was 
defined as hyperintensity compared to the surrounding liver 
parenchyma. Non-rim enhancement included hypointensity 
to homogeneous or heterogeneous hyperintensity compared 
to the surrounding liver parenchyma. The target appearance 
on hepatobiliary-phase images was defined as peripheral 
rim-like hypointensity compared with central hyperintensity 
in the lesion.
Two other observers with one and five years of 
experience, respectively and who were blinded to the 
clinical information and final diagnosis, reviewed the MR 
images randomly and independently two times before 
(session 1) and after (session 2) learning the results of 
the quantitative and qualitative analyses. Although the 
observers were aware that focal hepatic lesions in patients 
with extrahepatic malignancies had been confirmed as 
either FEI or metastasis, they were unaware of any other 
histopathological diagnoses or clinical findings. The interval 
between the reviews of MR images was at least one month. 
Each observer independently recorded lesions using a 
five point confidence scale: 1 = definite metastasis, 2 = 
probable metastasis, 3 = possible FEI, 4 = probable FEI, and 
5 = definite FEI. In clinical practice at our institution, the 
criteria used to distinguish FEI from metastasis on gadoxetic 
acid-enhanced MR images in session 1 included an irregular, 
non-spherical shape with fuzzy margins on T2-weighted 
images and more homogeneous hyperintensity during portal 
and 3-minute late phase images. A well-defined spherical 
shape with rim enhancement and a peripheral washout sign 
on dynamic images and hypointensity or target appearance 
on hepatobiliary phase images were considered indications 
of metastasis. Additional criteria used to distinguish FEI 
from metastasis on gadoxetic acid-enhanced MR images in 
session 2 included isointensity on T1-weighted images and 
emphasized ill-defined margin and size change between 
T2-weighted images and hepatobiliary phase images. 
All images were evaluated using a Picture Archiving and 
Communication System (PACS; PathSpeed, GE Medical 
Systems Integrated Imaging Solutions, MT. Prospect, IL) 
with an adjustment of the optimal window setting in each 
case. To avoid a mismatch between the true lesions and the 
scored lesions, each observer recorded the individual image 
number, the segmental location of all lesions, and the size 
of each lesion. For patients with two or more lesions in one 
segment, detailed descriptions of the location of the lesion 
in each segment were added in order to avoid confusion in 
the data analysis. Upon image review, the observers were 
aware that the sensitivity for FEI detection was calculated 
with the number of lesions that were assigned a confidence 
level of 4 or 5. All false-positive findings with confidence 
levels of 4 or 5 that were confirmed to be metastasis and 
all false-negative findings with confidence levels of 1, 2 
or 3 that were confirmed as FEI were assessed by observer 
consensus.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 442
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Statistical Analysis
The mean difference in the maximum dimension of the 
lesions 1 cm in diameter or larger, between T2-weighted 
and hepatobiliary-phase images in two groups was 
compared by the Student’s t tests. For a univariate analysis, 
statistical differences in morphologic findings and signal 
intensities on all sequences of MR images between FEI 
and metastasis were analyzed via the Chi-square test and 
Fisher’s exact test. Multivariate analyses using multiple 
logistic regressions were employed to determine the 
most significant MRI features for differentiating FEI from 
metastasis.
The sensitivity, specificity and diagnostic accuracy were 
calculated for each observer and each session, and the 
differences were statistically analyzed using McNemar test. 
The statistical analyses employed to test for the differences 
of calculated positive and negative predictive values for 
each observer and each session were based on a previous 
report (18). Significant differences were defined as p values 
less than 0.05.
Kappa statistics were used to evaluate interobserver 
agreement for the detection of FEI in each session. The 
degree of agreement was categorized as follows: kappa 
values of 0.00-0.20 were considered indicative of poor 
agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate 




The number of the lesions 1 cm in diameter or larger were 
comprised of 25 FEIs (mean, 16.5 mm; range, 10.1-34.6 
mm) and 60 metastases (mean, 22.1 mm; range, 10.4-61.9 
mm) on T2-weighted images. Table 1 shows the differences 
of the maximum dimension of the lesions 1 cm in diameter 
or larger between T2-weighted and hepatobiliary phase 
Table 1. Size Differences of Lesions ≥ 1 cm between 
T2-Weighted and Hepatobiliary Phase Images in Focal 







   0 ≤ n < 1.5 12 (48) 52 (87)
1.5 ≤ n < 3.0 5 (20)   7 (12)
3.0 ≤ n < 4.5 4 (16)   1 (2)
4.5 ≤ n < 6.0 4 (16)   0 (0)
Note.— Numbers in parentheses are percentages. FEI = focal 
eosinophilic infiltration, n = number
Table 2. MRI Findings of Focal Eosinophilic Infiltration and Metastasis in Liver
MRI Finding FEI (n = 39) Metastasis (n = 79) P Value
†
Margin* Ill defined 30 (77) 1 (1) < 0.0001
Well defined   9 (23) 78 (99)
Shape Non-spherical 25 (64) 1 (1) < 0.0001
Spherical 14 (36) 78 (99)
T1WI* Iso to high SI 32 (82) 3 (4)  0.0001
Low SI   7 (18) 76 (96)
T2WI High SI 36 (92) 77 (98)  0.6604
Iso to low SI 3 (8) 2 (3)
AP Rim E   8 (21) 62 (79)  0.0001
Non-rim E 31 (80) 17 (22)
PP  Rim E   6 (15) 59 (75)  0.0001
Non-rim E 33 (85) 20 (25)
LP Rim E 2 (5) 41 (52)  0.0001
Non-rim E 37 (95) 38 (48)
HBP Target app. (-) 37 (95) 33 (42)  0.0001
Target app. (+)  2 (5) 46 (58)
Note.— Numbers in parentheses are percentages. AP = arterial phase, app. = appearance, E = enhancement, FEI = focal 
eosinophilic infiltration, HBP = hepatobiliary phase, LP = 3-minute late phase, n = number, PP = portal phase, SI = signal 
intensity, T1WI = T1-weighted image, T2WI = T2-weighted image. 
†P values = univariate analysis, *On multivariate analysis, ill-
defined margin (p = 0.0155) and isointensity on T1-weighted images (p = 0.0028) were statistically significant.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 443
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images in the two groups. The size of FEIs and metastases 
on T2-weighted images were shown as unchanged in two 
FEIs (8%) and in four metastases (7%), increased in seven 
FEIs (28%) and in 43 metastases (72%), and reduced in 
16 FEIs (64%) and 13 metastases (22%), on hepatobiliary 
phase images. The mean difference in the maximum 
dimension of the lesions 1 cm in diameter or larger between 
two MR images in two groups were 2.1 mm (range, 0-5.1 
mm) in FEI and 0.7 mm (range, 0-3.6 mm), and were 
statistically significant (p < 0.001).
Qualitative Analysis
Univariate and Multivariate Analyses
Table 2 summarizes the different MRI features observed 
Fig. 1. 60-year-old man with gastric adenocarcinoma and focal eosinophilic infiltration (differential count of eosinophils was 
18%) in liver.
A. T2-weighted image shows non-spherical hyperintense lesion (arrow) in segment VIII. B. Unenhanced T1-weighted image shows 
isointensity of lesion (arrow). C-E. Gadoxetic acid-enhanced dynamic images show heterogeneous enhancement with slight hyperintensity 
(arrow) during arterial phase (C) and faint hypointensity (arrow) during portal (D) and 3-minute late phases (E). F. Hepatobiliary phase 
image obtained 20 minutes after injection of contrast agent shows ill-defined hypointense lesion (arrow) with slight increase in size (13.6 
mm on T2-weighted and 14.2 mm on hepatobiliary phase images) compared to A. Lesion spontaneously disappeared on follow-up CT (not 
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in the two groups. All FEIs and metastases appeared 
hypointense on hepatobiliary-phase images. On univariate 
analysis, all MRI features of FEIs were significantly different 
(p < 0.0001) except for hyperintensity on T2-weighted 
images in comparison with those of metastasis. 
Of the eight significant MRI features on univariate 
analysis, the results of the multivariate analyses 
demonstrated that ill-defined margin (p = 0.0155) and 
isointensity on T1-weighted images (p = 0.0028) (Fig. 1) 
were statistically significant features. Among the 39 FEIs, 25 
(64%) lesions in which ill-defined margins and isointensity 
on T1-weighted images manifested simultaneously, whereas 
there was only one (1%) such case among 79 metastases 
in the liver. The accuracy, sensitivity, and specificity of 
those combined MRI findings for differentiating FEI from 
metastasis were calculated as 87% (103 of 118), 64% (25 
of 39) and 99% (78 of 79), respectively.
Review of MR Images Before and After Recognition of 
Results 
Table 3 shows the sensitivity, specificity, diagnostic 
accuracy, as well as the positive and negative predictive 
values between two sessions for each observer. All observers 
had significantly higher sensitivities and negative predictive 
values in session 2 than session 1 (p < 0.05). Also, all 
observers achieved a higher accuracy in session 2 than in 
session 1 and the difference was statistically significant in 
observer 2 (p < 0.05).
Among the lesions misinterpreted as metastasis in 
session 1, nine (23%) and eight (21%) FEIs were correctly 
interpreted by observers 1 and 2, respectively, in session 
2. Among these, all observers correctly interpreted four 
FEIs in session 2 after being misinterpreted as metastasis 
in session 1 (Fig. 2) In a retrospective analysis, all four 
lesions showed isointensity on T1-weighted images 
irrespective of a well-defined margin and spherical shape in 
three lesions and rim enhancement on dynamic images in 
one lesion. Two of these lesions decreased in size and the 
remaining two lesions remained unchanged based on the 
comparison of hepatobiliary-phase images and T2-weighted 
images. Two metastases were misinterpreted as FEI by 
observer 1 in session 2, after being correctly interpreted 
in session 1. These lesions showed a spherical shape and 
no rim enhancement on dynamic images (Fig. 3). Only one 
FEI was misinterpreted as metastasis by all observers in 
both sessions. This lesion showed a well-defined margin, 
hypointensity on T1-weighted images, and rim enhancement 
on dynamic images; particularly in the arterial phase (Fig. 4). 
There were no FEIs that were interpreted as metastases in 
session 2 after being interpreted as FEIs in session 1.
The kappa values between the two observers for each 
session were in good agreement in session 1, and in 
excellent agreement in session 2 (Table 4).
DISCUSSION
Recently, a few reports have demonstrated the relatively 
high rate of coexistence of FEI and metastasis in the liver, 
which makes it difficult to differentiate FEI from hepatic 
metastasis in patients with extrahepatic malignancies in 
clinical practice (1, 3-5). Therefore, based on major MRI 
Table 3. Sensitivity, Specificity, Accuracy as well 
as Positive and Negative Predictive Values for 
Differentiating Focal Eosinophilic Infiltration (n = 39) 
from Metastasis (n = 79) in Liver
Session Observer 1 Observer 2
Sensitivity (%)
Session 1 74 (29) 74 (29)
Session 2 95 (37) 95 (37)
P value 0.02 0.01
Specificity (%)
Session 1 100 (79) 96 (76)
Session 2 98 (77) 100 (79)
P value 0.5 0.25
Accuracy (%)
Session 1 92 89
Session 2 97 98
P value 0.146 0.001
PPV (%)
Session 1 100 [29/29] (0) 91 [29/32] (3)
Session 2 95 [37/39] (2) 100 [37/37] (0)
P value 0.17 0.1
NPV (%)
Session 1 89 [79/89] (10) 88 [76/86] (10)
Session 2 98 [77/79] (2)   98 [79/81] (2)
P value 0.02 0.01
Note.— Numbers in parentheses in sensitivity, specificity, 
PPV and NPV are number of true positive, true negative, false 
positive and false negative lesions, respectively. For PPV, 
numbers in brackets are numbers of true-positive lesions 
divided by total number of lesions assigned confidence level 
of 4 or 5. For NPV, numbers in brackets are number of true-
negative lesions divided by total number of lesions assigned 
confidence level of 1, 2 or 3. n = number, NPV = negative 
predictive values, PPV = positive predictive valuesKorean J Radiol 12(4), Jul/Aug 2011 kjronline.org 445
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findings using high-field strength with a liver-specific 
agent such as gadoxetic acid, the precise differentiation 
of FEIs from metastases in the liver is critical for proper 
management.
Our results revealed that the changes in the sizes of FEIs 
between T2-weighted and hepatobiliary-phase images were 
significantly greater than those of metastases. However, 
the majority of FEIs (92%) and metastases (93%) increased 
or decreased in size on hepatobiliary phase-images when 
compared to T2-weighted images, which differed from the 
assertions of a previous report looking at metastasis (11). 
Several investigators reported that perfusion abnormalities 
and inflammatory changes around FEIs with various degrees 
of damage to hepatocyte function in them (11), as well as 
Fig. 2. 63-year-old man with colon adenocarcinoma and focal eosinophilic abscess, confirmed by biopsy (differential count of 
eosinophils in peripheral blood, 18%) in liver.
A. T2-weighted image shows spherical hyperintense lesion (arrow). B. Unenhanced T1-weighted image shows isointensity of lesion. C-E. 
Gadoxetic acid-enhanced dynamic images show rim enhancement (arrows) during arterial (C) portal phase (D) and 3-minute late phase 
(E). F. Hepatobiliary phase image obtained 20 minutes after injection of contrast agent shows well-defined hypointense lesion (arrow). 
Size difference between T2 (11.9 mm) and hepatobiliary phase (10.5 mm) was 1.4 mm. Slight decrease in size (11.9 mm on T2-weighted 
and 10.5 mm on hepatobiliary phase images) compared to A. Lesion was correctly interpreted as focal eosinophilic infiltration in session 
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changes including sinusoidal congestion, inflammatory cell 
infiltration and desmoplastic reactions around metastasis 
(20-23) may occur, which may be responsible for the size 
difference between T2-weighted and hepatobiliary-phase 
images.
Several studies (6, 8-12, 16) have described preferable 
MRI findings of FEIs in the liver. Non-spherical shape (76-
85%), ill-defined margin (79-90%), isointensity on T1 
weighted images (55-79%), hyperintensity on T2-weighted 
images (77-94%), and variable enhancement on dynamic 
imaging may be suggestive of FEIs (6, 8-10, 12, 16), which 





Fig. 3. 70-year-old man with rectal cancer and metastatic adenocarcinoma confirmed by intra-operative sonography-guided biopsy 
in liver (false-positive lesion). 
A. T2-weighted MR image shows spherical hyperintense lesion (arrow). B. Unenhanced T1-weighted image shows hypointense lesion 
(arrow). C. Gadoxetic acid-enhanced dynamic image shows no enhancement with hypointensity (arrow) during portal phase or arterial 
and 3-minute late phases (not shown). D. Hepatobiliary phase image obtained 20 minutes after injection of contrast agent shows well-
defined hypointense lesion (arrow) with no change in size compared to A. One of two observers misinterpreted it as focal eosinophilic 
infiltration in session 2, although it was correctly interpreted as metastasis in session 1.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 447
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of hepatic metastases in our study showed well-defined 
margin, spherical shape, hypointensity on T1-weighted 
images, hyperintensity on T2-weighted images, and rim 
enhancement on dynamic images as reported previously (20, 
24-27).
Several investigators (6, 7, 11, 24, 27) have reported 
that the typical imaging findings of hepatic metastasis 
included rim enhancement (40-92%) on dynamic images 
and a target appearance (63-85%) on gadobenate 





Fig. 4. 58-year-old man with colon cancer and focal eosinophilic abscess confirmed by percutaneous sonography-guided biopsy 
(differential count of eosinophils in peripheral blood, 2%) in liver (false-negative lesion). 
A. T2-weighted image shows non-spherical hypointense lesion (arrow). B. Unenhanced T1-weighted image shows hypointense lesion 
(arrow). C. Gadoxetic acid-enhanced dynamic images show rim enhancement (arrow) during arterial phase only (C) with hypointensity 
during portal and 3-minute late phases, without rim enhancement (not shown). D. Hepatobiliary phase image obtained 20 minutes after 
injection of contrast agent shows well-defined hypointense lesion (arrow). Size difference between T2 (21.5 mm) and hepatobiliary 
phase (21.3 mm) was 0.2 mm, which is minimal change in size (21.5 mm on T2-weighted and 21.3 mm on hepatobiliary phase images) 
compared to A. Lesion was misinterpreted as metastasis on both sessions by all observers.Korean J Radiol 12(4), Jul/Aug 2011 kjronline.org 448
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However, although less frequent in FEIs, 5-21% of FEIs 
in our study and 2-12% of FEIs in previous reports (6, 7, 
11, 24, 27) showed rim enhancement on dynamic imaging 
and 5% of FEIs in our study showed a target appearance 
hepatobiliary-phase MR images, which may make precise 
differentiation between the two groups difficult. We 
assume that perilesional enhancement of FEIs owing to 
increased vascular permeability caused by the inflammatory 
process or compensatory arterial overflow due to portal 
flow obstruction (8, 10, 11), could be sufficient to mimic 
the rim enhancement of metastasis. Several investigators 
(11, 24, 28) have suggested that the target appearance of 
hepatic metastasis may be caused by vascularized tumor 
cells in the periphery and abundant fibrosis and necrosis 
in the center on hepatobiliary-phase images. However, we 
believe that the target appearance of FEI may be imaged by 
variable degrees of central coagulative necrosis with liver 
cell damage, as reported previously (8, 10, 21-23).
Although several MRI features of FEIs that differ from 
those of hepatic metastases have been reported (6, 8-12, 
16), most decisive imaging findings for the differentiation 
of FEI from metastasis, as well as their usefulness in 
clinical practice, have not yet to be determined. Our results 
demonstrated that ill-defined margin and isointensity on 
T1-weighted images were the most useful MRI findings 
for distinguishing FEI from metastasis. We believe that 
the peripheral portion of FEI may have a high chance of 
contrast agent retention by the preserved functioning 
hepatocytes or inflammation, which may result in an ill-
defined margin relative to the peripheral portion of hepatic 
metastasis has abundant tumoral cellularity (21-23, 28, 
29), thus resulting in a well-defined margin.
Several investigators (20, 24-27) reported that the 
MRI features of hepatic metastasis commonly include 
hypointensity on T1 and hyperintensity on T2-weighted 
images, and these findings are attributable to a lack of 
glycogen within tumor cells and a relative increase in the 
amount of water in extracellular spaces or tumoral matrices 
(20). In our study, isointensity on T1-weighted images 
in FEIs was an important distinguishing finding that was 
different from hepatic metastasis. We speculate that the 
isointensity of FEI on T1-weighted images may result from 
smaller amounts of water due to the inflammatory process 
of FEI with a relatively lesser extent of necrosis and no 
change of vascularity compared to hepatic metastasis (28). 
Based on the verification of the usefulness of our results 
in clinical practice, all observers achieved higher sensitivity, 
diagnostic accuracy, and negative predictive value in session 
2 than in session 1. Our diagnostic accuracies (96-98%) 
in session 2 were superior to the 78% accuracy reported 
by Jang et al. (7). We believe that focused interpretation 
based on the most useful MRI findings in our study, may 
improve the diagnostic accuracy in distinguishing FEIs from 
metastasis. In our study, interobserver agreement in session 
2 was better than in session 1, which may be another 
positive finding confirming the usefulness of our results. 
In our study, two false-positive and four false-negative 
findings in session 2 developed due to the overlap of MRI 
findings with each other. Therefore, a histopathologic 
diagnosis such as a biopsy, should be conducted for any 
inconclusive lesions.
Our study has several limitations. First, hepatic 
metastases in most patients in our study consisted of 
adenocarcinoma, and whether results obtained on this basis 
can generally be applied to patients with various types 
of malignancies remains a matter of some controversy. 
Second, MRI findings of FEIs depend on the degree of 
inflammation and destruction of the liver parenchyma. In 
our study, not all FEIs were pathologically confirmed. As a 
result, the correlation between the MRI findings and the 
pathologic composition of large numbers of FEIs proved 
to be impossible. However, biopsies were not always 
performed, partially because the familiarity with the image 
findings of FEIs has reduced the need for further invasive 
study, and partially because FEIs were not clearly visible on 
sonography. 
In conclusion, our results demonstrate that with changes 
in the sizes of FEIs between T2-weighed and hepatobiliary-
phase images, ill-defined margin and isointensity on 
T1-weighted images are the most useful findings for 
differentiating FEIs from metastases in the liver on 
gadoxetic acid-enhanced 3.0T MRI.
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